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+Hospital Universitario Son Dureta, 
OCentre d’ Alt Rendimenf, Sant Cugat, 
Barcelona llHospita1 San Jorge, Huesca and nHospital Santiago Aposfol, Vitorial, Spain 
This study investigates the effects of moderate-high altitude on lung function and exercise performance in 46 
volunteers (19 females, 27 males), with a mean age of 42.45 1.4 years ( +_SEM) and varying smoking and exercise 
habits, who were not previously acclimatized. 
Measures obtained in the base camp (1140 m) and at altitude (2630 m), in random order, included forced 
spirometry, maximal voluntary ventilation, maximal inspiratory and expiratory pressures, arterial oxygen 
saturation and capillary lactate concentration after a standardized exercise test. The smoking history, Fagerstriim 
test and degree of habitual physical activity were also recorded for each participant. 
The percentage of smokers was similar in males (19%) and females (21%) (P=n.s.). Mean habitual physical 
activity index was 8.2kO.2 (range, 5.88-I 1.63). At the base camp, all lung function variables were within the 
normal range. Lactate concentration after exercise averaged 3.7kO.3 mm 1-l. No significant change was observed 
at altitude, except for a higher heart rate and a lower arterial oxygen saturation (SaO,) (both at rest and after 
inspiratory manoeuvres). The smoking history and the degree of physical activity did not influence lung function or 
exercise performance at altitude. 
The results of this study show that in middle-aged, healthy, not particularly well-trained individuals, lung 
function is not significantly altered by moderate-high altitude, despite the absence of any acclimatization period 
and independent of their smoking history and previous exercise habits. 
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Introduction 
The effects of high altitude on lung function has been the 
subject of numerous studies in the past (l-4). These studies 
were generally conducted in healthy, highly trained, young 
individuals, after some period of acclimatization. Yet, in 
real life, many middle-aged, untrained smokers often travel 
to sky resources around the world (which are located at a 
lower altitude, 200&3000 m) without any acclimatization 
period (5,6). Whether or not, and to what extent, lung 
function and/or exercise performance can be jeopardized 
under these conditions is unclear. The potential influence of 
smoking history and/or previous exercise habits of these 
subjects upon their physiological response to this moder- 
ate-high altitude is not known either. Accordingly, we 
conducted the present study in a group of middle-aged 
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volunteers (with varying smoking and exercise habits) who 
were studied without previous acclimatization in order to: 
1. determine the acute effects of moderate-high altitude 
(2630 m) upon lung function and exercise performance and 
2. investigate the potential influence of smoking-history and 
exercise habits upon this response. 
Methods 
STUDY SUBJECTS 
We studied 46 healthy volunteers (19 females, 27 males) 
among participants in a medical convention held in 
Benasque (Huesca, Spain). Table 1 shows their main 
anthropometric characteristics. They all normally lived at 
an altitude that range from sea level to 600,m. The smoking 
habits and the degree of habitual physical activity varied 
widely among them (Table 1). All gave their consent to 
participate after being fully informed of the nature, 
characteristics, risks and potential benefits of the study. 
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TABLE 1. Mean (+ SEM) of the main anthropometric and functional variables of all the subjects studied at the base camp 
(1140 m) 
Males Females 
(n = 19) (n= 19) 
Total 
(n = 46) 
Age (years) 
Weight (kg) 
Height (cm) 
Smokers (n, %) 
PA1 
FVC (% ref) 
FEVi (% ref) 
FEVJFVC (%) 
MMEF (% ret) 
PEF (% ref) 
MW (% ref) 
MIP (% ref) 
MEP (% ref) 
Heart rate (min-‘) 
SaOa (%) 
45.5+ 1.5 37.8 & 2.4** 42.4+ 1.4 
78.5k1.2 59.s+ 1.9** 70.8 + 1.7 
173.0+ 1.2 162.15 l.l** 168.5+_ 1.1 
5 (19%) 4 (21%) 9 (20%) 
8.5kO.3 7.9kO.3 8.2kO.2 
97.3k2.3 105.3 + 2.4* 100.6+ 1.7 
98.1 k2.5 105.Ok2.4 101.0+1.8 
77+1 80+_1 78+1 
88.7k4.6 93.9 k 6.2 90.8+ 3.7 
108.1& 3.9 111.8+4.1 109.7k2.8 
152.4k2.5 104.2f 1.7 132.0f3.9 
120.0-15.1 111.8k6.0 116.6k3.9 
118.3k4.9 126.60 121.6k3.8 
75.8k2.3 82.0f2.2 78.4* 1.7 
96.3 & 0.2 96.8 + 0.3 96.5kO.2 
A physical activity index (PAI) lower than 8 was considered indicative of sedentarism (8). Asterisks indicate significance of 
differences between sexs (*P<O-05; **P<O.Ol). FVC: forced vital capacity; FEVi: forced expiratory volume in 1 s; MMEF 
maximum mid-expiratory flow; PEF: peak expiratory flow; MW: maximum voluntary ventilation; MIP: maximal inspiratory 
pressure; MEP maximum expiratory pressure; SaOz: arterial oxygen saturation. 
STUDY DESIGN t 
We organized two different laboratories. The base camp 
was installed in Benasque (1140 m). The altitude laboratory 
was located at 2630 m in Pica Gallinero (Pyrinees, Spain). 
Table 2 presents the atmospheric conditions of both 
laboratories. For each participant, we recorded the smok- 
ing history and the degree of habitual physical activity. We 
also measured forced spirometry, maximal voluntary 
ventilation, maximal inspiratory and expiratory pressures, 
arterial oxygen saturation and capillary lactate concentra- 
tion after a standardized exercise test (see below). The 
anthropometric measures, as well as the clinical determina- 
tions (smoking history and degree of habitual physical 
activity), were determined at the base camp only. The 
remaining functional measures were taken both at the base 
camp and at altitude, in random order. All participants 
were studied within the first 24 h after leaving home. 
METHODS 
The smoking history and the Fagerstriim test (7) were 
recorded for each subject. The exhaled concentration of 
carbon monoxide (CO) was measured by a Mini III 
smokerlyzer EC50 (Bedfont Instruments, U.K.). The degree 
of habitual physical activity for each participant was 
quantified using the method proposed by Baecke et al. 
(8). Using this method, a physical activity index (PAI) 
lower than 8 was considered indicative of sedentary lifestyle 
(9). Spirometry (Fleish pneumotacograph, Datospir-500, 
Sibelmed, Barcelona, Spain) was obtained according to 
international guidelines (10). Reference values were those of 
a Mediterranean population (11). Maximal voluntary 
ventilation (MW) was determined over 15 s with the same 
spirometer (and compared to reference values) according to 
the method of Cotes (12). Maximal inspiratory and 
expiratory pressures (MIP and MEP, respectively) were 
measured (manometer-163, Sibelmed, Barcelona, Spain) 
according to the method described by Black and Hyatt (13). 
Reference values were those published by these same 
authors (13). The arterial oxygen saturation (SaOz) was 
determined by pulse oxymetry (Ohmeda, Biox 3740, BOC, 
Health Care, Louiseville, CO, U.S.A.) at rest and after 
three deep inspiratory manoeuvres. We recorded the time 
(s) from the last deep inspiration until the maximal SaOz 
value (recovery time). To assess exercise performance, 
capillary lactate concentration (mml- ‘) was measured by 
photometric analysis (Dr Lange Microphotometer Mini8, 
Berlin, Germany) from an arterialized blood sample 
obtained from the ear lobe 30-60 s after exercise (leg 
flexions at 1 Hz during 90 s) (14). 
ANALYSIS 
Data are shown as mean + SEM and range. Measurement at 
different altitudes were compared using the paired t-test. 
The statistical significance of differences between partici- 
pants of different sex, smoking history or exercise habits 
was assessed using the t-test for independent samples. 
Correlations between variables of interest were analysed 
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TABLE 2. Atmospheric working conditions (mean + SEM) at the base camp and at altitude 
Atmospheric pressure (mmHg) 
Ambient temperature (“C) 
Relative humidity (%) 
*P<o~ooo1. 
Base camp 
(1140 m) 
59350.1 
24kO.2 
39kO.4 
Altitude 
(2630 m) 
563_+3* 
12_+0.3* 
27f I* 
TABLE 3. Mean (-+sEM) values of several physiological variables studied at the base camp and at altitude 
Base camp Altitude 
(1140 m) (2630 m) 
Change 
WI 
Fvc (1) 
FEVl (1) 
FVCJFVC (%) 
MMEF (1 min-‘) 
PEF (1 s-l) 
MVV (1) 
MIP (cm HzO) 
MEP (cm H20) 
Heart rate (min- ‘) 
Sa02 basal (%) 
Sa02 hyper Vn (%) 
Recovery time (s) 
Lactate(mM 1-i) 
4.45+0.12 
3.47f0.10 
78 f 0.9 
3.11f0.14 
9.04kO.40 
144.2k4.3 
99.8 + 4.0 
144.5 _+ 5.9 
78.4-1: 1.7 
96.5kO.2 
98.2&0.1? 
16.5$- 1.2 
3.7kO.3 
4.45kO.12 
3.50+0.10 
79kO.8 
3.2120.15 
9.41 kO.40 
145.6A4.1 
98.2k4.0 
143.2h5.8 
88.4+2.2* 
92.5+_0.3* 
96.4+_0*3*? 
24.3+1.4* 
3.2f0.2 
0.03 + 0.6 
0.8kO.7 
0.8 + 0.5 
3.8_+ 1.8 
3.1k1.2 
1.0* 1.5 
-0.9+ 1.8 
-0.112.1 
13.9k2.8 
-4.1*0.3 
- 1.8kO.2 
91.7k28.3 
-13.7k7.2 
*P < 0.0 1 between altitudes; +P<O.Ol with respect to basal values. FVC: forced vital capacity; FEVi: forced expiratory 
volume in 1 s; MMEF: maximum mid expiratory flow; PEF: peak expiratory capacity; MW: maximum voluntary ventilation; 
MIP: maximal inspiratory pressure; MEP maximal expiratory pressure; SaOz: arterial oxygen saturation of haemoglobin with 
oxygen in internal blood. 
using the Spearman rank test. A P value lower 0.05 was 
considered sign&ant. 
Results 
The mean age of all participants was 42.4+ 1.4 years. 
Females were younger, lighter and smaller than males 
(Table 1). The percentage of smokers was similar in males 
(19%) and females (21%) (P= n.s.). Among smokers (n = 9) 
the Fagerstriim test averaged 4.9kO.7 points and exhaled 
CO 8~7+ 1.6 ppm. On average, participants could be 
classified as sedentary as shown by a mean PA1 of 
8.2+ 0.2 (Table 1); however, this value varied widely 
between participants, ranging from 5.88-l 1.63. 
At the base camp, all lung function variables were well 
within the normal range and no significant differences 
between males and females were observed, except for forced 
vital capacity (FVC) which was slightly higher in females 
(though normal in both cases) (Table 1). At altitude, these 
values remained basically unchanged, except for a higher 
heart rate and a lower SaO, value (both at rest and after 
ventilatory manoeuvres) and a prolongation of recovery 
time (Table 3). Interestingly, lactate concentration after 
exercise was similar at the base camp and at altitude (Table 
3). Table 4 presents the percent change at altitude of these 
physiological variables according to the smoking (yes/no) 
and exercise habits (PAI greater or lower than 8) of all 
subjects studied. In most cases, differences were not 
statistically significant. Only two variables (PEF‘in those 
with PAI> 8, and MIP in regular smokers) showed a 
statistical significant difference (Table 4). However, the 
absolute value of these changes are small and well within 
the variability of the measure. 
Discussion 
This study does not pretend to investigate the physiological 
effects of altitude upon lung function. This has been the 
subject of numerous studies in the past (14). It tries to fill a 
gap in the literature which relates to the potential effects of 
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TABLE 4. Percent chage at altitude (mean & SEM) of several physiological variables according to the smoking and exercise 
habits of the subjects studied 
Smoking history Exercise habitually 
(nr37) 
Yes 
(n=9) (28) 
Yes 
(n = 23) 
FVC (% change) 
FEVi (% change) 
FEVJFVC (% change) 
MMEF (% change) 
PEF (% change) 
MW (% change) 
MIP (% change) 
MEP (% change) 
Heart rate (% change) 
SaOZ basal (% change) 
SaOz hyper Ve (% change) 
Recovery time (% change) 
Lactate (% change) 
-0.lkO.7 0.6+_ 1.6 -0.1+1.0 0.4+ 1.0 
l.OkO.7 0.3+1.s -0.01 f 1.1 1.6+ 1.0 
1.1+0+6 -0.6f0.9 -0.6kO.7 1.4AO.8 
4.8k2.1 -0.lk3.1 3.1k2.9 5.5 f 2.8 
3.4kl.l 1.4k5.2 0.9+ 1.4 6.3 f 1.4* 
0.6&- 1.7 2.6k3.1 2.5k1.9 -0.2k2.2 
1.2k2.0 -9.6+3.5* -28k2.4 1.552.8 
-0.5k2.4 1.6k4.3 -4.4k3.5 3.7k2.8 
13.8k3.0 14.3 + 7.6 13.3&-4.4 13.8k3.9 
-4.OkO.4 -4~6+0.6 -4.5kO.6 -3.7kO.4 
-1.8kO.2 - 1.6f0.7 -1.8kO.4 - 1.9AO.3 
105.0-134.8 40.2k23.9 67.6k33.5 125.4k49.3 
- 16.4k8.5 0.2+ 1.0 - 18.7 + 10.7 12.0+9.2 
Asterisks indicate significance of differences between conditions (smoker vs. Non smoker and sedentarism vs. Non- 
sedentarism, respectively). (*P < 0.05; ** PcO.01). FVC forced vital capacity; FEVr: forced expiratory volume in 1 s; MMEF: 
maximum mid expiratory flow; PEF: peak expiratory flow; MW: maximum voluntary ventilation; MIP: maximal inspiratory 
pressure; MEP maximal expiratory pressure; SaO$ arterial oxygen saturation of haemoglobin with oxygen in internal blood. 
moderate (not extreme) altitude upon healthy (not athletic) 
subjects studied without previous acclimatization. This may 
be of interest for a vast number of individuals who are 
exposed to this altitude for tourist or recreational reasons 
worldwide. In this context, the main findings of this study 
were that, in a group of middle-aged, untrained, healthy 
subjects, the ascent to moderatehigh altitude does not 
influence lung function significantly. Further, this was not 
modified either by the smoking history or the exercise 
habits of the subject. 
The vast majority of studies investigating the effects of 
altitude upon lung function included young, highly-trained 
athletes, obtained measurements at very high altitude 
(6000-8000 m), and/or focused on the consequences of 
acclimatization or maximal exercise in these extreme 
conditions (l-4). Few other studies have been aimed at 
investigating the performance of the required measurement 
equipment in these circumstances (15,16). By contrast, there 
is very little information on the effects of moderate-high 
altitude (200&3000 m) upon lung function in middle-age, 
sedentary (or mildly active) healthy individuals, who are 
not specifically acclimatized and who ascend to this altitude 
only occasionally (5,6). Our study was specifically designed 
to investigate this particular type of individual under these 
special atmospheric conditions (Table 2). In this context, it 
is worth noting that because participants were not selected, 
they do not normally live at altitude and they were studied 
within the first 24 h of arrival in the ski resort, they are fully 
comparable to the normal middle-aged healthy population. 
Thus, our results provide a missing piece of information 
which, we believe, is important because all over the world, 
many of these subjects often move to this type of altitude 
for recreational purposes. 
In theory, moderate-high altitude can influence lung 
function through several putative mechanisms. Firstly, the 
decrease of atmospheric pressure that occurs with altitude 
reduces SaOz. The magnitude of SaOz reduction is 
modulated by the ventilatory response to hypoxia, a 
response that varies widely between individuals (17) and 
is significantly influenced by previous acclimatization (18). 
In our study, we observed that Sa02 fell with altitude from 
96.5 to 92.5%. This change is fully explained by the 1490 m 
difference between the base camp ,,,ed the altitude 
laboratory. Interestingly, even after the three ventilatory 
manoeuvres, SaOz was still lower at altitude than in the 
base camp (Table 3). Likewise, recovery time was pro- 
longed at altitude (Table 3). This is probably a reflection of 
the lower starting SaOz value,although the cooler ambient 
temperature of the altitude laboratory may have induced 
some peripheral vasoconstriction that also contributed to 
the delay in transit time from the lung to the finger capillary 
bed where SaOz was measured. 
Secondly, several factors may significantly influence 
spirometry at altitude (19). On the one hand, air becomes 
less dense with altitude. Therefore, airway resistance should 
decrease and both the inspiratory and expiratory flows 
should increase (20). On the ,other, the low ambient 
temperature characteristic of high altitude can induce 
bronchoconstriction, particularly’ in ‘subjects with mild 
airway hyper-reactivity (21). In keeping with previous 
studies (22, 23), we did not observe either an increase or 
decrease in any of the different spirometric indices assessed 
at altitude (Table 3). Probably, this lack of effect is due to 
the moderate altitude at which we measured lung function 
in our study and to an ambient temperature (Table 2) 
which was not low enough to elicit significant bronchocon- 
striction in our subjects. The reduction of FVC that may 
occur with altitude, in relation to an increased lung blood 
and/or interstitial oedema, occurs at a higher altitude 
(>SOOO m) (19). 
Thirdly, if SaOz decreases with altitude substantially (e.g. 
to less than 90%), respiratory and skeletal muscles may 
become poorly oxygenated. Theoretically, this may jeopar- 
dize their function, decreasing their strength and/or 
endurance capacity. In our subjects, respiratory muscle 
function (MIP, MEP, MW) was not impaired at altitude 
(Table 3). This is probably related to the fact that very few 
individuals showed an Sa02 value at altitude lower than 
90%. Also of note is the fact that lactate concentration 
after exercise at altitude was not different from that seen in 
the base camp (Table 3). This indicates that skeletal muscle 
function was not impaired by altitude in these group of 
subjects. 
Two final aspects of our study deserve comment. Firstly, 
neither smoking or exercise habits appeared to influence the 
response of lung function to altitude in these individuals. 
However, the number of smokers was small and the range 
of physical training relatively narrow. Secondly, the design 
of our study allowed us to test the reliability of several 
pieces of equipment, routinely used to measure lung 
function in many laboratories at sea level (spirometers, 
manometers and computers), under more extreme atmo- 
spheric conditions (Table 2). It was reassuring to observe 
that all of them worked correctly. 
In summary, our results show that lung function is not 
significantly altered by moderate-high altitude in middle- 
aged, healthy, not particularly well-trained individuals, 
despite the absence of any acclimatization period and 
independently of their smoking history and exercise habits. 
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